1. Home
  2. NBHC vs MNKD Comparison

NBHC vs MNKD Comparison

Compare NBHC & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NBHC

National Bank Holdings Corporation

N/A

Current Price

$39.65

Market Cap

1.6B

Sector

Finance

ML Signal

N/A

Logo MannKind Corporation

MNKD

MannKind Corporation

N/A

Current Price

$2.61

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NBHC
MNKD
Founded
2009
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2011
2004

Fundamental Metrics

Financial Performance
Metric
NBHC
MNKD
Price
$39.65
$2.61
Analyst Decision
Buy
Buy
Analyst Count
3
7
Target Price
$45.33
$8.64
AVG Volume (30 Days)
464.5K
6.3M
Earning Date
04-28-2026
05-29-2026
Dividend Yield
3.19%
N/A
EPS Growth
N/A
N/A
EPS
2.85
0.02
Revenue
$47,100,000.00
$348,966,000.00
Revenue This Year
$39.32
$33.40
Revenue Next Year
$6.74
$16.48
P/E Ratio
$14.11
$130.75
Revenue Growth
2.86
22.23
52 Week Low
$32.83
$2.59
52 Week High
$42.99
$6.51

Technical Indicators

Market Signals
Indicator
NBHC
MNKD
Relative Strength Index (RSI) 42.30 17.12
Support Level $37.79 N/A
Resistance Level $40.97 $6.08
Average True Range (ATR) 1.13 0.37
MACD -0.19 -0.18
Stochastic Oscillator 19.01 2.62

Price Performance

Historical Comparison
NBHC
MNKD

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp is a bank holding company. It provides various banking products and financial services to commercial, business, and consumer clients in the United States. The company offers deposit products including checking accounts, savings accounts, money market accounts, and other deposit accounts, including fixed-rate and fixed-maturity time deposits. It also provides commercial and industrial loans and leases. In addition, it offers treasury management solutions comprising online and mobile banking, commercial credit cards, wire transfers, automated clearing house, and electronic bill payments.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: